Asymptomatic COVID-19 Infection Among Healthcare Workers

NCT04354792 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2020-06-17

No results posted yet for this study

Summary

To assess the seroprevalence of SARS-CoV-2 IgG in Health care workers in three University Hospitals

Conditions

  • Immunologic Activity Alteration

Interventions

DIAGNOSTIC_TEST

Serum SARs COV 2 IGg screening in health care workers

Blood samples will be collected from the enrolled HCWs. Sample collection, processing, and laboratory testing will follow guidance from the World Health Organization

Sponsors & Collaborators

  • Kasr El Aini Hospital

    lead OTHER

Principal Investigators

  • Ahmed M Mukhtar, M.D · Cairo University

Eligibility

Min Age
25 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-05-01
Primary Completion
2020-06-10
Completion
2020-06-10

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04354792 on ClinicalTrials.gov